Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Nikiphorou

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Annals of the Rheumatic Diseases|September 12, 2025
Association of health literacy with disease outcomes in inflammatory arthritis: a systematic reviewMrinalini Dey, Shyam Budhathoki, Helen Elwell, et al.
Rheumatology (Oxford, England)|February 10, 2026
Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDsCasper Webers, Augusta Ortolan, Elena Nikiphorou, et al.
Rheumatology Advances in Practice|January 19, 2022
The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritisMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology International|September 10, 2023
Ongoing shielding behavior one year post COVID-19: results from a longitudinal study of patients with inflammatory arthritisMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology Advances in Practice|December 13, 2023
Mental health, quality of life and self-management behaviours: online evaluation of inflammatory arthritis patients over 1 year of COVID-19 lockdownsMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology (Oxford, England)|October 9, 2024
Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?Zonne L M Hofman, Nadia M T Roodenrijs, Elena Nikiphorou, et al.
Rheumatology (Oxford, England)|March 21, 2026
Treatment satisfaction, disease severity and healthcare use in patients with axial spondyloarthritis in the United States and EuropeElena Nikiphorou, Alexis Ogdie, Dan Twigg, et al.
Arthritis Research & Therapy|October 30, 2016
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literatureElena Nikiphorou, Helga Radner, Katerina Chatzidionysiou, et al.
Rheumatology (Oxford, England)|April 16, 2019
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Benjamin D Clarke, Andrew I Rutherford, et al.
Rheumatology International|May 13, 2026
Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohortNelly Ziade, Ihsane Hmamouchi, Marc Moussallem, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Annals of the Rheumatic Diseases|September 12, 2025
Association of health literacy with disease outcomes in inflammatory arthritis: a systematic reviewMrinalini Dey, Shyam Budhathoki, Helen Elwell, et al.
Rheumatology (Oxford, England)|February 10, 2026
Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDsCasper Webers, Augusta Ortolan, Elena Nikiphorou, et al.
Rheumatology Advances in Practice|January 19, 2022
The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritisMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology International|September 10, 2023
Ongoing shielding behavior one year post COVID-19: results from a longitudinal study of patients with inflammatory arthritisMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology Advances in Practice|December 13, 2023
Mental health, quality of life and self-management behaviours: online evaluation of inflammatory arthritis patients over 1 year of COVID-19 lockdownsMelissa Sweeney, Lewis Carpenter, Savia de Souza, et al.
Rheumatology (Oxford, England)|October 9, 2024
Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?Zonne L M Hofman, Nadia M T Roodenrijs, Elena Nikiphorou, et al.
Rheumatology (Oxford, England)|March 21, 2026
Treatment satisfaction, disease severity and healthcare use in patients with axial spondyloarthritis in the United States and EuropeElena Nikiphorou, Alexis Ogdie, Dan Twigg, et al.
Arthritis Research & Therapy|October 30, 2016
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literatureElena Nikiphorou, Helga Radner, Katerina Chatzidionysiou, et al.
Rheumatology (Oxford, England)|April 16, 2019
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Benjamin D Clarke, Andrew I Rutherford, et al.
Rheumatology International|May 13, 2026
Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohortNelly Ziade, Ihsane Hmamouchi, Marc Moussallem, et al.
Pageof 23